Future Horizons in the Global Sexually-Transmitted Disease MarketPublished by: Venture Planning Group Published: Aug. 31, 2012 - 350 Pages Table of ContentsSexually-Transmitted Diseases Global Market Outlook and Emerging Opportunities I. Introduction II. Worldwide Market and Technology Overview A. Major Infectious Disease Tests 1. Chancroid a. Background b. Diagnostic Tests c. Vaccines and Drugs 2. Chlamydia a. Background b. Diagnostic Tests c. Vaccines and Drugs 3. Gonorrhea a. Background b. Diagnostic Tests c. Vaccines and Drugs 4. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs Human Herpes Virus-6 (HHV-6) a. Background b. Diagnostic Tests c. Vaccines and Drugs 5. Papillomavirus (HPV) a. Background b. Diagnostic Tests c. Vaccines and Drugs 6. Syphilis a. Background b. Diagnostic Tests c. Vaccines and Drugs B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers C. Emerging Diagnostic Technologies 1. Molecular Diagnostics 2. Monoclonal Antibodies 3. Immunoassays 4. Differential Light Scattering 5. Information Technology 6. Artificial Intelligence 7. Liposomes 8. Flow Cytometry 9. Chromatography 10. Diagnostic Imaging 11. Gel Microdroplets 12. Other III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares IV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market Shares V. Italy: Market Size, Growth and Major Suppliers’ Sales and Market Shares VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares VIII. UK: Market Size, Growth and Major Suppliers’ Sales and Market Shares IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - Gen-Probe - Hologic - ID Biomedical - Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako Sexually-Transmitted Diseases Global Market Outlook and Opportunities List of Tables Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Pap Smear/HPV Tests Major Companies Developing or Marketing Syphilis Tests France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment France Chlamydia Diagnostics Sales by Major Supplier France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment France Gonorrhea Testing Market Diagnostics Sales by Major Supplier France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment France Herpes Testing Market Diagnostics Sales by Major Supplier France PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment France Syphilis Testing Market Diagnostics Sales by Major Supplier Germany Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment Germany Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment Germany Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment Germany Gonorrhea Testing Market Diagnostics Sales by Major Supplier Germany Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment Germany Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment Germany Herpes Testing Market Diagnostics Sales by Major Supplier Germany PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment Germany Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment Germany Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment Italy Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment Italy Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment Italy Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment Italy Gonorrhea Testing Market Diagnostics Sales by Major Supplier Italy Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment Italy Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment Italy Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment Italy PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment Italy Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment Japan Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment Japan Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment Japan Chlamydia Diagnostics Sales by Major Supplier Japan Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier Japan Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment Japan Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment Japan Herpes Testing Market Diagnostics Sales by Major Supplier Japan PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment Japan Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment Japan Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment Japan Syphilis Testing Market Diagnostics Sales by Major Supplier Spain Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment Spain Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment Spain Chlamydia Diagnostics Sales by Major Supplier Spain Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment Spain Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment Spain Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment Spain Herpes Testing Market Diagnostics Sales by Major Supplier Spain PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment Spain Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment Spain Syphilis Testing Market Diagnostics Sales by Major Supplier U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier U.K. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Herpes Testing Market Diagnostics Sales by Major Supplier U.K. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Chancroid Diagnostics Sales by Major Supplier U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Chlamydia Diagnostics Sales by Major Supplier U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier U.S.A. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier AbstractThis report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:- Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for STD testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted. Contains 350 pages and 90 tables Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch. Get full details about this report >> |
|
|
|
About MarketResearch.com
|
||
|
|
On the WEB
1/17/2013 - 32